OTCMKTS:CHEOF Cochlear (CHEOF) Stock Forecast, Price & News $159.80 -3.46 (-2.12%) (As of 10/3/2023 ET) Add Compare Share Share Today's Range$159.80▼$159.8050-Day Range$150.29▼$176.3052-Week Range$118.43▼$176.30Volume2 shsAverage Volume257 shsMarket CapitalizationN/AP/E Ratio97.32Dividend Yield0.79%Price TargetN/A ProfileProfileChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestProfileChartCompetitorsFinancialsHeadlinesSEC FilingsShort Interest Cochlear MarketRank™ ForecastAnalyst RatingN/AUpside/DownsideN/AShort InterestBearishDividend StrengthWeakBased on Four FactorsSustainabilityN/ANews Sentiment0.33Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.20 out of 5 stars N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Cochlear. Previous Next 2.0 Short Interest Percentage of Shares ShortedShort Interest Ratio / Days to CoverCochlear has a short interest ratio ("days to cover") of 77.5, which indicates bearish sentiment.Change versus previous monthShort interest in Cochlear has recently decreased by 13.58%, indicating that investor sentiment is improving significantly. Previous Next 0.8 Dividend Strength Dividend YieldCochlear pays a meaningful dividend of 2.07%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthCochlear does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Cochlear is 77.34%. Payout ratios above 75% are not desirable because they may not be sustainable. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CHEOF. Previous Next 1.9 News and Social Media Coverage News SentimentCochlear has a news sentiment score of 0.33. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.50 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Cochlear this week, compared to 0 articles on an average week. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Cochlear insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 22.47% of the stock of Cochlear is held by institutions. Previous Next 1.3 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Cochlear is 99.42, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 113.48.Price to Earnings Ratio vs. SectorThe P/E ratio of Cochlear is 99.42, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 105.80. Previous Next See Top Rated MarketRank™ Stocks Here About Cochlear (OTCMKTS:CHEOF) StockCochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.Read More CHEOF Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CHEOF Stock News HeadlinesOctober 4, 2023 | americanbankingnews.comHead-To-Head Analysis: Cochlear (OTCMKTS:CHEOF) and Conformis (NASDAQ:CFMS)October 3, 2023 | americanbankingnews.comAnalyzing Tenon Medical (NASDAQ:TNON) & Cochlear (OTCMKTS:CHEOF)October 4, 2023 | Behind the Markets (Ad)Laser breakthrough could send stock soaring 2,467%Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...July 26, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Terns Pharmaceuticals (TERN) and Cochlear Limited (OtherCHEOF)July 20, 2023 | msn.comChandy’s Cochlear Implant Scheme hits hurdles, parents seek government helpJuly 19, 2023 | benzinga.comSensorion Submits Clinical Trial Application for OTOF-GT, its Lead Gene Therapy Candidate, in EuropeJuly 18, 2023 | msn.com7-year-old girl hears for first time after Chhattisgarh govt sponsors operation, father wants her to become doctorJuly 18, 2023 | msn.comOommen Chandy: Humane leader who put patients first, say health expertsOctober 4, 2023 | Oxford Club (Ad)AI Stock Caught Trading Under Secret NameWe have uncovered perhaps the most unusual AI stock we've ever seen.It's expected to see massive revenue this year - $215 billion. The company holds over 29,000 patents in the U.S. It pays an enormous dividend.July 10, 2023 | markets.businessinsider.comMorgan Stanley Keeps Their Hold Rating on Cochlear Limited (CHEOF)July 10, 2023 | benzinga.comSensorion Submits Clinical Trial Application for Lead Gene Therapy Candidate OTOF-GT in the UKJuly 5, 2023 | benzinga.comSensorion Reports Positive Efficacy Data from SENS-401 Phase 2a Clinical StudyJune 25, 2023 | msn.comRajasthan: Govt announces ₹1 lakh airfare for travel for organ transplantJune 25, 2023 | thetimes.co.ukNHS may have missed thousands of deaf children in ‘huge national failure’June 22, 2023 | morningstar.comFTSE 100 Closes Down 0.75% After Rate Hike; Ocado Surges on Bid SpeculationJune 22, 2023 | afr.comLabor bows to pressure on multinational tax disclosureJune 19, 2023 | finance.yahoo.comSensorion Reports Promising Preliminary Data from SENS-401 Phase 2a Clinical StudyMay 22, 2023 | afr.com‘Next Cochlear’ stock surges after heart device breakthroughMay 4, 2023 | marketwatch.comCochlear Implants Market Share | Business till 2030May 3, 2023 | msn.comParents to inform SA cochlear implant reviewApril 20, 2023 | msn.comTownsville University Hospital staff stood down amid review of paediatric audiology unit outcomesApril 16, 2023 | afr.comAustralian business delegation heads to ChinaApril 11, 2023 | msn.comSurgeries of chronically ill children in Pune pending under RBSKApril 6, 2023 | marketwatch.comCochlear Implant (CI) Systems Market 2023-2030| Expert Analysis of Current Trend and Scope to Drive the MarketApril 6, 2023 | marketwatch.comSensorion Announces Candidate Selection for GJB2 Gene Therapy ProgramMarch 22, 2023 | uk.news.yahoo.comDad runs half marathon to help deaf babies like his sonMarch 22, 2023 | nasdaq.comCochlear, Demant contest UK regulator's Oticon deal concernsSee More Headlines Receive CHEOF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cochlear and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS Industry Medical Devices Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:CHEOF CUSIPN/A CIK1453930 Webwww.cochlear.com Phone(129) 428-6555FaxN/AEmployees4,800Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio97.32 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesMr. Diggory William Howitt BE (Hons) (Age 56)MBA, CEO, MD, Pres & Exec. Director Comp: $3.07MMr. Stuart SayersChief Financial OfficerMr. Jan Janssen MSc Elec Eng (Age 58)Chief Technology Officer Comp: $1.31MMs. Karen O'DriscollChief Information OfficerMs. Kristina DevonVP of Investor RelationsMs. Jennifer StevensonVP of Corp. Communications & BrandMr. Dean PhizackleaSr. VP of Global Strategic MarketingMs. Jennifer HornerySr. VP of Global People & CultureMr. Greg Bodkin BE (Hons)MComm (UNSW), Sr. VP of Global Supply ChainMr. Anthony BishopPres of Asia Pacific & Latin AmericaMore ExecutivesKey CompetitorsAmbu A/SOTCMKTS:AMBBYBICO Group AB (publ)OTCMKTS:CLLKFCaliber Imaging & DiagnosticsOTCMKTS:LCDXCell MedXOTCMKTS:CMXCCellaVision AB (publ)OTCMKTS:CLVSFView All Competitors CHEOF Stock - Frequently Asked Questions How have CHEOF shares performed in 2023? Cochlear's stock was trading at $135.00 at the beginning of 2023. Since then, CHEOF shares have increased by 18.4% and is now trading at $159.7950. View the best growth stocks for 2023 here. Are investors shorting Cochlear? Cochlear saw a decline in short interest in the month of September. As of September 15th, there was short interest totaling 85,300 shares, a decline of 13.6% from the August 31st total of 98,700 shares. Based on an average daily trading volume, of 1,100 shares, the short-interest ratio is currently 77.5 days. View Cochlear's Short Interest. Is Cochlear a good dividend stock? Cochlear (OTCMKTS:CHEOF) pays an annual dividend of $1.27 per share and currently has a dividend yield of 2.07%. The dividend payout ratio is 77.34%. Payout ratios above 75% are not desirable because they may not be sustainable. What is Cochlear's stock symbol? Cochlear trades on the OTCMKTS under the ticker symbol "CHEOF." How do I buy shares of Cochlear? Shares of CHEOF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Cochlear's stock price today? One share of CHEOF stock can currently be purchased for approximately $159.80. How many employees does Cochlear have? The company employs 4,800 workers across the globe. How can I contact Cochlear? Cochlear's mailing address is 1 University Avenue, Sydney, New South. The official website for the company is www.cochlear.com. The company can be reached via phone at (129) 428-6555. This page (OTCMKTS:CHEOF) was last updated on 10/4/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cochlear Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.